Company intelligence / Profile preview
Cardium Therapeutics, Inc.
San Diego, California, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
Cardium Therapeutics was a San Diego-based health sciences company focused on regenerative medicine and innovative therapies addressing cardiovascular diseases and wound care. Its lead product candidates included Generx®, a DNA-based gene therapy for myocardial ischemia that advanced through late-stage clinical trials, and Excellagen™, an FDA-cleared topical gel for chronic wounds. The company also developed the InnerCool Therapies endovascular cooling system before selling this business to Philips in July 2009. In March 2014, following a strategic collaboration with Shanxi Taxus Pharmaceuticals Co., Ltd., the company changed its name to Taxus Cardium Pharmaceuticals Group Inc.
- Therapeutic areas
- CardiovascularEndocrinology
- Modalities
- DNA-based therapeuticsTopical gelsMedical devices for therapeutic hypothermiaNutraceuticals/lifestyle products
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Strategic collaboration/funding with Shanxi Taxus Pharmaceuticals Co., Ltd.
Beyond the preview
Go deeper on Cardium Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cardium Therapeutics, Inc..